mutation and clinical parameters in PTC, such as progression, invasion, and recurrence. The aim of this study was to evaluate the association between BRAF protein overexpression and the BRAF V600E ... mutation and BRAF…
mutation results in the substitution of valine for glutamic acid at position 600 of the BRAF protein, which consequently becomes constitutively activated. The present study investigated the BRAF V600E mutation…
required. The aim of this study was to estimate the diagnostic value of BRAF V600E mutation status, cytomorphological features, and combination of both these features for diagnosis of papillary thyroid ... assigned to…
malignancy of the endocrine system. The most frequent genetic alteration in PTC is V600E mutation in BRAF gene which leads to changes in the activity of intracellular signaling pathways ... ITGA9, ITGB1 and their…
with its variant and splenic marginal zone lymphoma. The presence of kinase-activating BRAF V600E mutation in classical HCL clone and in no other mature B-cell lymphomas/ leukemia ... sequencing demonstrated that…
oncogenic BRAF V600E mutation has recently been found in a substantial number of Langerhans cell histiocytosis (LCH) cases. We developed and validated a rapid and sensitive high-resolution melting ... analysis–based…
best exemplified by BRAFV600E mutation. Numerous studies have demonstrated a strong association of BRAF V600E mutation with poor clinicopathological characteristics of PTC, such as lymph node metastasis, extrathyroidal…
investigate the correlations of V-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene mutations with the clinicopathologic features of papillary thyroid carcinoma and central lymph node metastasis. We…
synaptophysin - leading to the diagnosis of malignant epithelioid glioneuronal tumor. Genotyping revealed a BRAF V600E mutation. Patient had stable disease until recurrence at 10 months post-operatively. Malignant…
regarding the clinicopathological characteristics of papillary thyroid carcinoma (PTC). Methods: In this study BRAF V600E mutation was detected in 50 patients with PTC by immunohistochemical staining and assessed with…
BRAF V600E mutation analysis has been an important companion diagnostic assay to evaluate prognosis of malignant melanoma and to guide target therapy with BRAF inhibitor. The aim of this study ... specificity of…
role in the pathogenesis of papillary thyroid cancer (PTC). In this study, a BRAF V600E mutation was detected in formalin-fixed and paraffin-embedded PTC samples using multiplex allele-specific
case positive for BRAF V600E mutation. For the positive case, targeted gene sequencing (total 50-gene panel including BRAF) was followed which confirmed BRAF V600E (c.1799T ... mutation. The patient with BRAF mutated…
threonine kinase, mediates the RAS/RAF/MAPK signal transduction pathway. Over 90% of BRAF mutations are V600E (c.1796T>A); this activates mitogenic cascades leading to tumorigenesis. Th is mutation ... COLD-PCR…
have enhanced our understanding of the pathogenesis of these tumors, with genetic mutations such as BRAF V600E in ameloblastomas providing insights into targeted therapies. Treatment modalities vary according
cytological examination. We found contemporary BRAF p. (Val600Glu) (p. (V600E); c. 1799T>A) and NRAS p. (Gln61Arg) (p. (Q61R); c.182A>G) mutations in morphologically different areas within the same lobe ... right one)…
number, we undertook a multi-institute survey of BRAF mutations in adult smokers. We found BRAF V600E ... mutations in 57% of our cohort of 61 patients. No significant relation with age or gender and BRAF status was…
Purpose The aim of this study is to investigate the predictive value of BRAF V600E mutation for the persistence of papillary thyroid cancer (PTC) after total thyroidectomy and routine central ... elevated rate of…
than in codon 13 (3/32) and G12D (43.8%) is the most frequent mutation. BRAF v600E mutation is observed in proximal colon in 3 of 5 tumors (60%) in patients
inverse association between the numbers of solar keratoses and excised skin cancers and BRAF V600E mutational status. Older patients were more likely to have melanomas harboring BRAF V600K or NRAS ... cumulative sun…
were positive for the BRAF V600E gene mutation, but 73.0% of malignant nodules had this mutation (p=0.000). Among patients with and without the BRAF V600E gene mutation
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.